Monoubiquitination of the nonhomologous end joining protein XRCC4.
Nonhomologous end joining is one of the major pathways by which cells repair double-strand breaks, and the XRCC4-DNA ligase IV complex is required for the ligation step. To better understand the regulation and stability of XRCC4 and DNA ligase IV, we investigated the ubiquitination status of these two proteins. We identified a predominantly monoubiquitinated form of XRCC4, and higher molecular weight forms of ubiquitinated XRCC4 were detected in lower abundance. In response to etoposide-induced DNA damage, ubiquitinated XRCC4 became more pronounced and was additionally phosphorylated. We confirmed that DNA ligase IV is unstable in the absence of XRCC4, with a half-life of approximately 30-90 min. Unlike XRCC4, we did not detect ubiquitinated forms of DNA ligase IV, and we found that the presence of XRCC4 stabilized DNA ligase IV more significantly than proteasome inhibitors. Monoubiquitination of XRCC4 may play a critical role in the regulation of nonhomologous end joining.
Foster
Rebecca E
RE
Department of Pathology, University of Chicago, IL 60637, USA.
Nnakwe
Chinonye
C
Woo
Leslie
L
Frank
Karen M
KM
D002460:Cell Line; D004249:DNA Damage / Q000502:physiology*; D000072481:DNA Ligase ATP; D011088:DNA Ligases / Q000378:metabolism*; D004260:DNA Repair / Q000502:physiology*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D006801:Humans; D025801:Ubiquitin / Q000378:metabolism*
D004268:DNA-Binding Proteins; C000607893:LIG4 protein, human; D025801:Ubiquitin; C101467:XRCC4 protein, human; D011088:DNA Ligases; D000072481:DNA Ligase ATP